Germany / Highest Honours for BioNTech Founders; Bayer’s Growth Predictions; Merck Making Further French Investments
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
Address: Werner-von-Siemens-Straße 22-28
64625 Bensheim
Tel: +49 (0) 6251 – 1083-0
Web: http://www.koehler-chemie.de/deutsch/startseite/
Dr. Franz Köhler Chemie, the company, specialises in organ-protecting solutions, therapeutics, x-ray contrast agents and antidotes. On this basis, Dr. Gernot Köhler, from the second generation, has expanded the company into an innovative, research-intensive and high performance pharmaceuticals company in Alsbach, the USA and Russia. Distributing associates represent the company worldwide. Internal research makes innovative products and continuous development possible. As a result, new therapeutic approaches are formulated in close co-operation with qualified doctors and research is carried out effectively and dependent on requirements. “We are at your service” is the mission statement with which we shall continue to contribute to advances in science and medicine in the interests of the user and patients alike.
Dr. Franz Josef Köhler founded the company in 1959. He is the founder of aspartic therapy and a promoter of organ-protecting solutions. In his honour, the German Society for Thoracic and Cardiovascular Surgery has awarded the “Franz J. Köhler Award” every year since 1990, for outstanding work in the field of organ protection with special emphasis on the heart. His son, Dr. Gernot Köhler, has headed this modern medium sized company since 1984, guiding it into new areas of business.
Dr. Franz Köhler Chemie produces at two German locations thereby meeting the increasing international demand for organ-protecting solutions. The products, perfusion, infusion and injection solutions from Alsbach and Bensheim in South Hesse are in a leading position internationally.
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant…
PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to…
Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number…
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
Some of the top recent stories from Germany, Europe’s leading pharma market according to CPhI, including big…
Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as…
German giant Merck KGaA has announced a EUR one billion investment into its headquarters in Darmstadt, Germany up…
As a majority family owned group, Merck is also the oldest pharmaceutical company in the world and known throughout…
The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth…
DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with…